Eli Lilly 2010 Annual Report Download - page 66

Download and view the complete annual report

Please find page 66 of the 2010 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 164

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164

FORM 10-K
Fair Value of Financial Instruments
The following tables summarize certain fair value information at December 31 for assets and liabilities measured at
fair value on a recurring basis, as well as the carrying amount and amortized cost of certain other investments:
Fair Value Measurements Using
Description Carrying
Amount Amortized
Cost
Quoted
Prices in
Active
Markets
for
Identical
Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3) Fair
Value
December 31, 2010
Cash and cash equivalents .................. $5,993.2 $5,993.2 $2,138.6 $3,854.6 $ $5,993.2
Short-term investments
Commercial paper ....................... $ 540.8 $ 540.8 $ $ 540.8 $ $ 540.8
U.S. government and agencies ............ 128.9 128.9 128.9 128.9
Corporate debt securities ................. 63.4 63.9 63.4 63.4
Other securities ......................... 0.7 0.7 0.7 0.7
Short-term investments .................. $ 733.8 $ 734.3
Noncurrent investments
U.S. government and agencies ............ $ 359.2 $ 361.8 $ 359.2 $ $ $ 359.2
Corporate debt securities ................. 367.9 368.9 367.9 367.9
Mortgage-backed ....................... 315.5 350.7 315.5 315.5
Asset-backed ........................... 132.4 140.8 132.4 132.4
Other debt securities ..................... 6.4 8.3 3.3 3.1 6.4
Marketable equity ....................... 433.7 182.6 433.7 433.7
Equity method and other investments(1) ..... 164.4 164.4
Investments ............................ $1,779.5 $1,577.5
December 31, 2009
Cash and cash equivalents .................. $4,462.9 $4,462.9 $1,826.7 $2,636.2 $ $4,462.9
Short-term investments
U.S. government and agencies ............ $ 18.5 $ 18.8 $ 18.5 $ $ $ 18.5
Corporate debt securities ................. 15.8 16.1 15.8 15.8
Other securities ......................... 0.4 0.4 0.4 0.4
Short-term investments .................. $ 34.7 $ 35.3
Noncurrent investments
U.S. government and agencies ............ $ 81.3 $ 81.7 $ 81.3 $ $ $ 81.3
Corporate debt securities ................. 185.9 195.4 185.9 185.9
Mortgage-backed ....................... 240.3 310.0 240.3 240.3
Asset-backed ........................... 78.7 94.1 78.7 78.7
Other debt securities ..................... 34.4 12.8 3.6 30.8 34.4
Marketable equity ....................... 378.7 184.0 378.7 378.7
Equity methods and other investments(1) .... 156.5 156.5
Investments ............................ $1,155.8 $1,034.5
(1) – Fair value not applicable
54